Interleukin-inhibitors

J&J's Tremfya approved, further crowding IL-inhibitor market
BioPharma Dive
Sat, 07/15/17 - 11:31 am
JNJ
Tremfya
psoriasis
Interleukin-inhibitors
guselkumab